rs1047972
| Orientation | minus |
| Stabilized | minus |
| Geno | Mag | Summary |
|---|---|---|
| (G;G) | 0 | common/normal |
| Make rs1047972(A;A) |
| Make rs1047972(A;G) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 20 |
| Position | 56386407 |
| Gene | AURKA |
| is a | snp |
| is | mentioned by |
| dbSNP | rs1047972 |
| dbSNP (classic) | rs1047972 |
| ClinGen | rs1047972 |
| ebi | rs1047972 |
| HLI | rs1047972 |
| Exac | rs1047972 |
| Gnomad | rs1047972 |
| Varsome | rs1047972 |
| LitVar | rs1047972 |
| Map | rs1047972 |
| PheGenI | rs1047972 |
| Biobank | rs1047972 |
| 1000 genomes | rs1047972 |
| hgdp | rs1047972 |
| ensembl | rs1047972 |
| geneview | rs1047972 |
| scholar | rs1047972 |
| rs1047972 | |
| pharmgkb | rs1047972 |
| gwascentral | rs1047972 |
| openSNP | rs1047972 |
| 23andMe | rs1047972 |
| SNPshot | rs1047972 |
| SNPdbe | rs1047972 |
| MSV3d | rs1047972 |
| GWAS Ctlg | rs1047972 |
| GMAF | 0.1561 |
| Max Magnitude | 0 |
| ? | (A;A) (A;G) (G;G) | 28 |
|---|---|---|
|
| ||
influences mitosis
associated with cancer
[PMID 21050672] Genetic variants of NPAT-ATM and AURKA are associated with an early adverse reaction in the gastrointestinal tract of patients with cervical cancer treated with pelvic radiation therapy
[PMID 16465622
] Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.
[PMID 18854777] Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy.
[PMID 25253995] Association between genetic polymorphisms in AURKA (rs2273535 and rs1047972) and breast cancer risk: a meta-analysis involving 37,221 subjects
[PMID 26925658] Association of CYP2E1, STK15 and XRCC1 Polymorphisms with Risk of Breast Cancer in Malaysian Women.
[PMID 27270838] Association of the AURKA and AURKC gene polymorphisms with an increased risk of gastric cancer.
[PMID 29333101] Variations in the AURKA Gene: Biomarkers for the Development and Progression of Hepatocellular Carcinoma.
[PMID 33050100] Impact of Aurora Kinase A Polymorphism and Epithelial Growth Factor Receptor Mutations on the Clinicopathological Characteristics of Lung Adenocarcinoma.
